Christina Larkin
Equibles does not estimate personal net worth.
Get an email with a short summary when Spero Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SPRO alertsAbout Christina Larkin
Christina Larkin is recorded as COO at Spero Therapeutics, Inc. (SPRO). The proxy statement of Spero Therapeutics, Inc. reports total compensation of $991,962 for Christina Larkin in fiscal 2020, including a base salary of $404,052. Disclosed compensation is on record for 3 fiscal years. Spero Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Spero Therapeutics, Inc. includes Esther Rajavelu (CEO, CFO and Board Member), Ankit Mahadevia, M.D. (Chairman), Frank E. Thomas (Chairman) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Spero Therapeutics, Inc.
- Esther Rajavelu CEO, CFO, Board Member
- Ankit Mahadevia, M.D. Chairman
- Frank E. Thomas Chairman
- Frank Thomas Chairman
- Stephen J. DiPalma CFO
- Tim Keutzer COO
- Timothy Keutzer COO
- Satyavrat Shukla Chief Accounting Officer
- Cynthia Smith Board Member
- John C. Pottage Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Spero Therapeutics, Inc. (SPRO) | Chief Operating Officer | $404,052 | $991,962 |
| 2019 | Spero Therapeutics, Inc. (SPRO) | Chief Operating Officer | $394,167 | $947,983 |
| 2018 | Spero Therapeutics, Inc. (SPRO) | Chief Operating Officer | $385,000 | $533,799 |
Recent activity
No call appearances or filed executive changes recorded yet.